Euractiv.com Est. 1min 30-03-2023 (updated: 05-05-2023 ) Content-Type: Underwritten Underwritten Produced with financial support from an organization or individual, yet not approved by the underwriter before or after publication. Back pain is a common symptom of multiple myeloma, a rare cancer of plasma cells found in the bone marrow. [SHUTTERSTOCK] Euractiv is part of the Trust Project >>> Languages: Français | DeutschPrint Email Facebook X LinkedIn WhatsApp Telegram The people-centred approach of the European Commission’s flagship Beating Cancer plan may be pivotal in understanding and treating patients of multiple myeloma. Despite substantial improvements in multiple myeloma patients’ outcomes, most people living with this incurable blood cancer experience relapses as the disease develops resistance to therapies. The findings of a qualitative study show that the most important treatment characteristics for myeloma patients across Europe are those which target life expectancy, life-threatening side effects, treatment response, nerve or bone problems, thinking problems, and reduced energy. In this European Special report, the EURACTIV network explores the care pathway of myeloma patients across Europe as well as the latest innovation in terms of therapies. Download PDF Multiple myeloma patients face late diagnosis, unequal access to therapies News | Health 30-03-2023 Est. 6minDelayed diagnosis and inequalities in access to treatments across the EU are among the main challenges in fighting multiple myeloma, an incurable and rare form of blood cancer. Long waiting lists challenge Italy’s progress in myeloma treatment News | Diabetes, Cancer, Hepatitis 03-05-2023 Est. 4minDespite progress in innovative drugs and treatments related to multiple myeloma in Italy, long waiting lists in public health facilities still poses severe obstacles, patients warn. Access to innovative myeloma drugs remains ‘difficult’ in France News | Health 28-04-2023 Est. 5minOver the past ten years, treatments for multiple myeloma have progressed significantly, allowing French patients to live longer. However, much progress remains to be made, particularly in access to innovative drugs. Innovative therapies bring hope for German myeloma patients News | Health 27-04-2023 Est. 5minAlmost 7,000 Germans come down with multiple myeloma, an aggressive form of bone-marrow cancer, every year. While mortality rates remain high, research is moving fast and recent studies show signs of hope for patients. Multiple myeloma patients in Spain face regional disparities News | Health 25-04-2023 Est. 5minIn an interview with EuroEFE, Regueiro recalls that multiple myeloma, an incurable form of plasma cell cancer, can have continuous relapses. Multiple myeloma therapies in Poland are becoming increasingly effective News | Health 24-04-2023 Est. 7minTreatment of multiple myeloma has come a long way in Poland as the state has added more therapies in its reimbursable drug programme, stakeholders have said but stressed the need for more efforts on potential bone marrow donors who provide another vital treatment option.
